Wenfeng Wu

609 total citations
31 papers, 468 citations indexed

About

Wenfeng Wu is a scholar working on Dermatology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Wenfeng Wu has authored 31 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Dermatology, 6 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in Wenfeng Wu's work include Lipoproteins and Cardiovascular Health (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and Acne and Rosacea Treatments and Effects (5 papers). Wenfeng Wu is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and Acne and Rosacea Treatments and Effects (5 papers). Wenfeng Wu collaborates with scholars based in China, Pakistan and Myanmar. Wenfeng Wu's co-authors include Qiang Li, Wen‐Ting Wei, Zhuxian Wang, Qing‐Qing Kang, Qiang Liu, Huoji Chen, Shijian Xiang, Hongxia Zhu, Jin‐Hong Lin and Yucai Cao and has published in prestigious journals such as PLoS ONE, Scientific Reports and Green Chemistry.

In The Last Decade

Wenfeng Wu

28 papers receiving 461 citations

Peers

Wenfeng Wu
Corina Tatomir Romania
Cong Yan China
Mohammed Bhia Iran
Yücel Başpınar Türkiye
Mahmoud M. A. Elsayed Egypt
Xiaochang Liu China
Ju‐Yen Fu Malaysia
Yunbo Sun China
Poonam Kushwaha India
Fumie Hashimoto Japan
Corina Tatomir Romania
Wenfeng Wu
Citations per year, relative to Wenfeng Wu Wenfeng Wu (= 1×) peers Corina Tatomir

Countries citing papers authored by Wenfeng Wu

Since Specialization
Citations

This map shows the geographic impact of Wenfeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Wu more than expected).

Fields of papers citing papers by Wenfeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Wu. The network helps show where Wenfeng Wu may publish in the future.

Co-authorship network of co-authors of Wenfeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Wu. A scholar is included among the top collaborators of Wenfeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Wu. Wenfeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jingyi, et al.. (2024). Investigating the proliferative inhibition of HepG2 cells by exosome-like nanovesicles derived from Centella asiatica extract through metabolomics. Biomedicine & Pharmacotherapy. 176. 116855–116855. 15 indexed citations
2.
Wu, Wenfeng, et al.. (2024). Bridging the gap: exploring the causal relationship between metformin and tumors. Frontiers in Genetics. 15. 1397390–1397390. 2 indexed citations
3.
4.
Wu, Wenfeng, Nasreen Nasreen, Ayman A. Swelum, et al.. (2024). Computational investigation of turmeric phytochemicals targeting PTR1 enzyme of Leishmania species. Heliyon. 10(6). e27907–e27907. 2 indexed citations
5.
Wu, Wenfeng, Qing Zhou, Rui Jin, et al.. (2022). Insights into the evolution of the ISG15 and UBA7 system. Genomics. 114(2). 110302–110302. 2 indexed citations
6.
Zhou, Jin, et al.. (2022). TLN2 functions as a tumor suppressor in clear cell renal cell carcinoma via inactivation of the Wnt/β-catenin signaling pathway. Translational Andrology and Urology. 11(1). 39–52. 9 indexed citations
7.
Hu, Yi, Wenfeng Wu, Zhuxian Wang, et al.. (2022). Explore the Anti-Acne Mechanism of Licorice Flavonoids Based on Metabonomics and Microbiome. Frontiers in Pharmacology. 13. 832088–832088. 18 indexed citations
8.
Chen, Tingting, Zhuxian Wang, Wenfeng Wu, et al.. (2021). A Skin Lipidomics Study Reveals the Therapeutic Effects of Tanshinones in a Rat Model of Acne. Frontiers in Pharmacology. 12. 675659–675659. 18 indexed citations
9.
Chen, Tingting, Zhuxian Wang, Yaqi Xue, et al.. (2021). Integrated Proteomics and Metabolomics Link Acne to the Action Mechanisms of Cryptotanshinone Intervention. Frontiers in Pharmacology. 12. 700696–700696. 18 indexed citations
10.
Yang, Jin, Nana Zhang, LV Jun, et al.. (2020). Comparing the performance of conventional PCR, RTQ-PCR, and droplet digital PCR assays in detection of Shigella. Molecular and Cellular Probes. 51. 101531–101531. 34 indexed citations
11.
Wang, Zhuxian, Li Liu, Shijian Xiang, et al.. (2020). Formulation and Characterization of a 3D-Printed Cryptotanshinone-Loaded Niosomal Hydrogel for Topical Therapy of Acne. AAPS PharmSciTech. 21(5). 159–159. 40 indexed citations
12.
Xiang, Shijian, Wenfeng Wu, Zhuxian Wang, et al.. (2020). Potential role of mTORC1 and the PI3K-Akt pathway in anti-acne properties of licorice flavonoids. Journal of Functional Foods. 70. 103968–103968. 19 indexed citations
13.
14.
Xiang, Shijian, Huoji Chen, Xiaojun Luo, et al.. (2018). Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling. Journal of Experimental & Clinical Cancer Research. 37(1). 184–184. 46 indexed citations
15.
Xiang, Shijian, Chi-On Chan, Qun Shen, et al.. (2018). Altered metabolites in guinea pigs with allergic asthma after acupoint sticking therapy: New insights from a metabolomics approach. Phytomedicine. 54. 182–194. 7 indexed citations
16.
Jiang, Long, Wenfeng Wu, Panpan Chen, et al.. (2016). The use of targeted exome sequencing in genetic diagnosis of young patients with severe hypercholesterolemia. Scientific Reports. 6(1). 36823–36823. 13 indexed citations
17.
Zhang, Yong‐Biao, Long Jiang, Ning Wan, et al.. (2015). Identification of the gene defect responsible for severe hypercholesterolaemia using whole-exome sequencing. Scientific Reports. 5(1). 11380–11380. 9 indexed citations
18.
Wu, Wenfeng, et al.. (2014). Use of Targeted Exome Sequencing in Genetic Diagnosis of Chinese Familial Hypercholesterolemia. PLoS ONE. 9(4). e94697–e94697. 16 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Corina Tatomir Breakdown of academic impact, for papers by Cong Yan Breakdown of academic impact, for papers by Mohammed Bhia Breakdown of academic impact, for papers by Yücel Başpınar Breakdown of academic impact, for papers by Mahmoud M. A. Elsayed Breakdown of academic impact, for papers by Xiaochang Liu Breakdown of academic impact, for papers by Ju‐Yen Fu Breakdown of academic impact, for papers by Yunbo Sun Breakdown of academic impact, for papers by Poonam Kushwaha Breakdown of academic impact, for papers by Fumie Hashimoto
Rankless by CCL
2026